Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with bleomycin effectively treats plantar warts with fewer sessions.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Spironolactone may help reduce hair loss in androgenic alopecia.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document concludes that choosing the right forehead and brow lifting technique based on individual patient characteristics is crucial to prevent complications and achieve desired results.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

FFA has higher long-term remission rates than LPP.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

A 3-year-old girl developed scurvy symptoms that improved with vitamin C but relapsed when supplementation stopped.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Combining hysteroscopy with Diane-35 improves outcomes and reduces recurrence of endometrial polyps.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Endoscopic forehead and brow lifting safely and consistently improves aged eyebrows, but may have complications.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.